Skip to main content

11 Reasons Why INVRS is Better Than Excel Alone

INVRS and Excel

If you work with your own investment models you likely use excel to build them, but excel isn’t ideal for many reasons and it costs you in other ways. 

First, you need good data and it isn’t just lying around in an easy to import format.  You’re either keying it in yourself or paying money for excel downloads.  

When you need data from numerous sources – price information, data from different statements and across multiple years - you must merge it from multiple sheets.  It's an inefficient process which can lead to data corruption.

After all this data is collected and merged, models built and tested, the net result is one statistic for one company.  A stand-alone number without context has limited use.  To be meaningful, you need to compare it to similar companies.  
  
This is just a sample of the challenges.  You need software that overcomes these problems and is designed for investment model creation.

Surprise!  This software exists, it's INVRS and here's how it solves the problems associated with using excel alone for investment analysis.

1.       It fetches your data for you. 
Just point and click for the data points you want. 

2.       You build the model in the software using familiar operators and not in an obscure programming language.
Suppose you want to calculate the forward dividend yield and compare it to the five year average and score/rank the quotient.  You can create this in INVRS using the same operators and shortcuts you use in excel, optionally validating your equations as you go.

3.       Each model is a template that can be used repeatedly.
No need to establish another data source, no risk of it breaking and no need to copy and paste each time you have a new stock to analyze.  Once you’ve built your model you can run it repeatedly on different stocks. 

4.       You can experiment.
Change any of the elements in your models, whether data or formula. 

5.       Perform peer-based analysis.
Running a model against one stock hardly seems worth it because there’s no context for the result.  With peer-based analysis, you can answer the question “how does my target company compare to similar companies?”

6.       It archives every analysis automatically.
In excel, refreshing data can lead to the loss of an old analysis. Your ideal software would never let that happen. 

7.       Find every archived analysis easily. 
You can search chronologically, by portfolio and by template.  An important feature when you are doing hundreds or thousands of analyses. 

8.       No flipping between data source and formula.
Best practice in excel separates data and formula.  Sometimes you can keep everything on one sheet, often you can’t.  Flipping between sheets is a pain when you are checking a complicated formula and if you combine your formulas and data, reproducing it or changing variables becomes difficult.
INVRS separates data and formula while keeping it all visible on screen.

9.       Fast graphing.
You can create graphs of your analyses.  You can sort the results, add a benchmark, annotate and export.  It's easier than in excel and supports other options specific to investment analysis, such as price graphing.


10.   Create notes or articles.
If you discover interesting information, you might want to share it.  Make notes as you go along and evolve them into articles you can publish or share.

11.   It pays you.
You get paid to use the software, whether it is posting your analyses or recommending it to other users.

Go to invrs.com and sign up for a free trial or request a sample analysis.  Experience the power of INVRS for investment research.

Comments

Popular posts from this blog

A Value Opportunity in Bausch Health

Overview: Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products.

The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment refers to the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of ne…

NextEra - Good Dividend in the Renewable Energy Sector

NextEra had good results relative to a group of peers in a factor-based analysis.NextEra has an appealing profitability and income profile.Its price momentum looks decent, with a caveat.Its relatively small size (a small mid-cap) coupled with its industry (renewable energy) further weight the odds that this company could be a strong performer in the future.
The Analysis Overview
I created a portfolio of stocks in the alternative energy sector, looking specifically for companies with a market cap over $1B but less than $4B.  This is a sweet spot that offers strong potential for growth but is also substantial enough not to be too speculative.

It's my believe that alternative energy is on the ascendance, where as fossil fuels will inevitably decline (NextEra isn't a pure play in this regard however, natural gas assets are part of its portfolio).  If you share this belief and you want exposure to this market, NextEra looks like a good bet.

This is a factor-based analysis on seven …

Twilio - Growth Isn't Reasonably Priced

Overview: Twilio, Inc. engages in the provision of communications software, cloud-based platform and services. Its developer-first platform approach consists of programmable communications cloud, super network, and business model for innovators. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke.

Founded: 2008
Number of Employees: 996
Headquarters: San Francisco US
CEO: Jeff Lawson

Analysis Methodology: We'll keep TWLO's business model in mind as we analyze it.  They're an enabling company - they provide tools to help other companies deliver on their objectives.  They help their customers focus on their core business by providing a robust platform where they can quickly, easily and for less money (presumably)  build the ancillary features they need to be successful, namely customer support.  They're a B2B business using a SaaS model.  They are "developer-centric".  I interpret this to mean they are focusing on the developer in their …